ARK Genomic Revolution ETF (ARKG)
BATS: ARKG · Real-Time Price · USD
37.81
-1.01 (-2.60%)
At close: Jul 24, 2026, 4:00 PM EDT
37.70
-0.11 (-0.29%)
After-hours: Jul 24, 2026, 8:00 PM EDT
ARKG Holdings Information
ARKG is an equity ETF with a total of 32 individual holdings. The top holdings are 10x Genomics stock at 7.90%, Tempus AI at 7.74%, Twist Bioscience at 7.41%, Personalis at 6.70%, and CRISPR Therapeutics AG at 6.31%.
Total Holdings
32
Top 10 Percentage
59.45%
Asset Class
Equity
ETF Category
Health
Assets
1.58B
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TXG | 10x Genomics, Inc. | 7.90% |
| 2 | TEM | Tempus AI, Inc. | 7.74% |
| 3 | TWST | Twist Bioscience Corporation | 7.41% |
| 4 | PSNL | Personalis, Inc. | 6.70% |
| 5 | CRSP | CRISPR Therapeutics AG | 6.31% |
| 6 | ABSI | Absci Corporation | 6.19% |
| 7 | GH | Guardant Health, Inc. | 4.41% |
| 8 | LLY | Eli Lilly and Company | 4.39% |
| 9 | BEAM | Beam Therapeutics Inc. | 4.22% |
| 10 | ILMN | Illumina, Inc. | 4.18% |
| 11 | NTRA | Natera, Inc. | 4.01% |
| 12 | VCYT | Veracyte, Inc. | 3.01% |
| 13 | CDNA | CareDx, Inc. | 2.94% |
| 14 | CMPS | COMPASS Pathways plc | 2.86% |
| 15 | RXRX | Recursion Pharmaceuticals, Inc. | 2.75% |
| 16 | BFLY | Butterfly Network, Inc. | 2.36% |
| 17 | NRIX | Nurix Therapeutics, Inc. | 2.34% |
| 18 | NTLA | Intellia Therapeutics, Inc. | 2.33% |
| 19 | ADPT | Adaptive Biotechnologies Corporation | 2.28% |
| 20 | SDGR | Schrödinger, Inc. | 2.05% |
| 21 | WGS | GeneDx Holdings Corp. | 1.74% |
| 22 | IONS | Ionis Pharmaceuticals, Inc. | 1.67% |
| 23 | ALMR | Alamar Biosciences, Inc. | 1.47% |
| 24 | CERS | Cerus Corporation | 1.36% |
| 25 | PRME | Prime Medicine, Inc. | 1.31% |
As of Jul 14, 2026